Literature DB >> 266841

Acute leukemia after azathioprine treatment of connective tissue disease.

E Alexson, K D Brandt.   

Abstract

A 23-year-old man is reported who had a connective tissue disorder with features of rheumatoid arthritis and systemic lupus erythematosus. Because of the development of severe myocarditis and acute cerebral dysfunction treatment with azathioprine and prednisone was instituted, with dramatic clinical improvement. Ten months later, when a total of some 52 g of azathioprine had been administered, acute myelomonocytic leukemia developed. Although acute myelogenous leukemia has been noted in several individuals receiving immunosuppressive drugs for treatment of lymphoreticular neoplasms, this complication has heretofore been rare in patients given azathioprine for non-neoplastic disease. The present case is documented because of the increasing use of immunosuppressive drugs in treatment of various rheumatic disorders and the need to establish the relationship, if any, between the use of such agents and malignancy.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 266841

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  8 in total

1.  The age-risk relationship of hematologic malignancies in patients with rheumatoid arthritis: a nationwide retrospective cohort study.

Authors:  Yu-Chih Lin; Hui-Wen Chou; Wen-Chan Tsai; Jeng-Hsien Yen; Shun-Jen Chang; Yi-Ching Lin
Journal:  Clin Rheumatol       Date:  2015-05-20       Impact factor: 2.980

Review 2.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

3.  Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.

Authors: 
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

4.  Acute megakaryoblastic leukaemia in a patient with systemic lupus erythematosus.

Authors:  M Colović; G Janković; V Lazarević; A Novak
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

5.  [Acute leukemia after kidney allotransplantation (author's transl)].

Authors:  D Frei; U Binswanger; J Fehr; J Briner; C Sauter; F Largiadèr
Journal:  Blut       Date:  1980-05

6.  Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report.

Authors:  M A Sobas; T Wróbel; K Zduniak; M Podolak-Dawidziak; J Rybka; M Biedroń; M Sawicki; J Dybko; K Kuliczkowski
Journal:  Case Rep Hematol       Date:  2017-07-20

7.  Risk of malignancies in patients with inflammatory bowel disease who used thiopurines as compared with other indications: a territory-wide study.

Authors:  Kelvin Y C Zheng; Chuan-Guo Guo; Irene O L Wong; Lijia Chen; Ho Yin Chung; Ka Shing Cheung; Wai K Leung
Journal:  Therap Adv Gastroenterol       Date:  2020-11-18       Impact factor: 4.409

8.  Risks of myeloid malignancies in patients with autoimmune conditions.

Authors:  L A Anderson; R M Pfeiffer; O Landgren; S Gadalla; S I Berndt; E A Engels
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.